ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 87 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,020 | -99.6% | 269 | -99.3% | 0.00% | -100.0% |
| Q4 2022 | $459,962 | +17.9% | 40,813 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $390,000 | -39.3% | 40,813 | -48.7% | 0.00% | 0.0% |
| Q2 2022 | $642,000 | -37.7% | 79,587 | +30.5% | 0.00% | -50.0% |
| Q1 2022 | $1,030,000 | +15.9% | 61,000 | +47.2% | 0.00% | +100.0% |
| Q4 2021 | $889,000 | -60.3% | 41,430 | +36.6% | 0.00% | -75.0% |
| Q3 2021 | $2,238,000 | +35.1% | 30,331 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $1,657,000 | – | 30,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $163,929,000 | 36.34% |
| Logos Global Management LP | 3,011,352 | $50,892,000 | 6.60% |
| Vivo Capital, LLC | 4,220,048 | $71,319,000 | 4.91% |
| Samsara BioCapital, LLC | 262,786 | $4,441,000 | 1.12% |
| Cormorant Asset Management, LP | 712,079 | $12,034,000 | 0.92% |
| Pier Capital, LLC | 394,443 | $6,666,000 | 0.85% |
| Redmile Group, LLC | 772,397 | $13,054,000 | 0.41% |
| Artal Group S.A. | 500,000 | $8,450,000 | 0.35% |
| Nan Fung Group Holdings Ltd | 41,950 | $709,000 | 0.34% |
| Orbimed Advisors | 621,700 | $10,507,000 | 0.17% |